• Whatsapp:+8613373397217
  • 24/7 ER :+8613373397217
  • mailbox:bjtsthospital@gmail.com
HOME > Information >
  • The new EU proposal: metformin can be safely used for modera

    Update Time:2016-12-18 11:19:40 Click Rate:73

    The European Medicines Agency (EMA) has also announced that metformin is safe for the treatment of moderate renal impairment in patients with type 2 diabetes, following the FDA's expansion of the indication for metformin and its safe use in ...[readmore]

  • FDA strengthens Invokana, Farxiga kidney risk warning

    Update Time:2016-12-18 11:19:01 Click Rate:78

    On June 14, 2016, FDA issued a drug safety newsletter to modify the SGLT2 inhibitor Invokana / Invokamet and Farxiga / Xigduo XR label warnings to add information on acute kidney injury and how to minimize the risk of kidney damage. ...[readmore]

  • Gospel of patients with lupus nephritis: Voclosporin

    Update Time:2016-12-18 11:18:34 Click Rate:196

    The AURA study published by the American College of Rheumatology Association (ACR / ARHP) in 2016 shows that most patients with lupus nephritis receiving low-dose voclosporin therapy receive complete remission. ...[readmore]

home page pre page 1 2 3 4 5 next page last page total pages 5 13 records
Kidney DiseaseMore >>